# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
92943, Journal, 0, 15, "Diabetes Care .", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasJournal> \"Diabetes Care .\"."
92929, PublicationYear, 16, 20, "2001", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasPublicationYear> \"2001\"."
92916, Title, 48, 161, "Basal insulin therapy in type 2 diabetes : 28 - week comparison of insulin glargine ( HOE 901 ) and NPH insulin .", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasTitle> \"Basal insulin therapy in type 2 diabetes : 28 - week comparison of insulin glargine ( HOE 901 ) and NPH insulin .\"."
92459, Type2Diabetes, 73, 88, "type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
16, Duration, 91, 100, "28 - week", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasCTduration> \"28 - week\"."
92952, InsulinGlargine, 115, 131, "insulin glargine", "", "<http://ctro/data#Medication_24343> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlargine>."
92949, IsophaneInsulin_NPH, 148, 159, "NPH insulin", "", 
92931, Author, 183, 194, "Schwartz SL", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasAuthor> \"Schwartz SL\"."
92937, Author, 197, 208, "Clark CM Jr", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasAuthor> \"Clark CM Jr\"."
92930, Author, 211, 218, "Park GD", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasAuthor> \"Park GD\"."
92932, Author, 221, 230, "Donley DW", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasAuthor> \"Donley DW\"."
92938, Author, 233, 243, "Edwards MB", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasAuthor> \"Edwards MB\"."
92928, Country, 326, 329, "USA", "", "<http://ctro/data#Country_24280> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country>. <http://ctro/data#Population_24277> <http://ctro/data#hasCountry> <http://ctro/data#Country_24280>."
167, ObjectiveDescription, 383, 572, "To determine the safety and efficacy of the long - acting analog insulin glargine compared with NPH insulin in patients with type 2 diabetes who were previously treated with insulin alone .", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasObjectiveDescription> \"To determine the safety and efficacy of the long - acting analog insulin glargine compared with NPH insulin in patients with type 2 diabetes who were previously treated with insulin alone .\"."
92954, InsulinGlargine, 448, 464, "insulin glargine", "", 
312, IsophaneInsulin_NPH, 479, 490, "NPH insulin", "", 
62, Precondition, 494, 570, "patients with type 2 diabetes who were previously treated with insulin alone", "", 
92953, Type2Diabetes, 508, 523, "type 2 diabetes", "", 
109, Insulin, 557, 564, "insulin", "", 
92466, Precondition, 618, 735, "subjects with type 2 diabetes who were receiving NPH insulin with or without regular insulin for postprandial control", "", "<http://ctro/data#Population_24277> <http://ctro/data#hasPrecondition> \"subjects with type 2 diabetes who were receiving NPH insulin with or without regular insulin for postprandial control\"."
316, Type2Diabetes, 632, 647, "type 2 diabetes", "", 
92460, IsophaneInsulin_NPH, 667, 678, "NPH insulin", "", 
110, Insulin, 703, 710, "insulin", "", 
92463, Randomized, 741, 751, "randomized", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
92955, InsulinGlargine, 763, 779, "insulin glargine", "", 
24, InsulinGlargine, 782, 789, "HOE 901", "", 
106179, Frequency, 792, 802, "once daily", "", "<http://ctro/data#Intervention_24328> <http://ctro/data#hasFrequency> \"once daily\"."
111, NumberPatientsArm, 809, 812, "259", "", "<http://ctro/data#Arm_24310> <http://ctro/data#hasNumberPatientsArm> \"259\"."
92461, IsophaneInsulin_NPH, 818, 829, "NPH insulin", "", "<http://ctro/data#Medication_24350> <http://ctro/data#hasDrug> <http://ctro/data#IsophaneInsulin_NPH>."
106180, Frequency, 830, 849, "once or twice daily", "", "<http://ctro/data#Intervention_24334> <http://ctro/data#hasFrequency> \"once or twice daily\"."
112, NumberPatientsArm, 855, 858, "259", "", "<http://ctro/data#Arm_24319> <http://ctro/data#hasNumberPatientsArm> \"259\"."
92959, Duration, 865, 873, "28 weeks", "", 
106178, OpenLabel, 880, 892, "open - label", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
106181, Multicenter, 895, 906, "multicenter", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
106182, DoseDescription, 915, 986, "Doses were adjusted to obtain target fasting glucose < 6 . 7 mmol / l .", "", "<http://ctro/data#Medication_24343> <http://ctro/data#hasDoseDescription> \"Doses were adjusted to obtain target fasting glucose < 6 . 7 mmol / l .\". <http://ctro/data#Medication_24350> <http://ctro/data#hasDoseDescription> \"Doses were adjusted to obtain target fasting glucose < 6 . 7 mmol / l .\"."
153, FastingPlasmaGlucose_target, 952, 984, "fasting glucose < 6 . 7 mmol / l", "", 
121, Millimoles_per_litre, 976, 984, "mmol / l", "", 
164, TimePoint, 990, 1005, "study end point", "", 
159, Insulin, 1031, 1038, "insulin", "", 
63, DoseValue, 1073, 1079, "0 . 75", "", 
117, IntUnit_per_Kg, 1080, 1087, "IU / kg", "", 
39, HbA1c, 1152, 1157, "HbA1c", "", "<http://ctro/data#Endpoint_24285> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
181, TimePoint, 1163, 1171, "baseline", "", 
182, TimePoint, 1175, 1184, "end point", "", 
92948, IntentionToTreat, 1188, 1207, "intent - to - treat", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasAnalysisApproach> <http://ctro/data#IntentionToTreat>."
162, Mean, 1223, 1227, "mean", "", 
46, Mean, 1237, 1236, "", "", 
40, HbA1c, 1257, 1262, "HbA1c", "", 
183, TimePoint, 1268, 1276, "baseline", "", 
184, TimePoint, 1280, 1289, "end point", "", 
92960, InsulinGlargine, 1309, 1325, "insulin glargine", "", 
92897, Reduction, 1336, 1342, "0 . 41", "", 
92946, SdDevChangeValue, 1349, 1354, "0 . 1", "", 
147, Percentage, 1355, 1356, "%", "", 
34, IsophaneInsulin_NPH, 1367, 1370, "NPH", "", 
50, Reduction, 1381, 1387, "0 . 59", "", "<http://ctro/data#Outcome_24384> <http://ctro/data#hasChangeValue> \"0 . 59\"."
92945, SdDevChangeValue, 1394, 1399, "0 . 1", "", 
148, Percentage, 1400, 1401, "%", "", 
41, HbA1c, 1450, 1455, "HbA1c", "", 
92944, BaseLineValue, 1473, 1478, "8 . 5", "", "<http://ctro/data#Outcome_24357> <http://ctro/data#hasBaselineValue> \"8 . 5\". <http://ctro/data#Outcome_24384> <http://ctro/data#hasBaselineValue> \"8 . 5\"."
128, Percentage, 1479, 1480, "%", "", "<http://ctro/data#Endpoint_24285> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
52, ObservedResult, 1483, 1565, "The treatments were associated with similar reductions in fasting glucose levels .", "", 
42, FastingPlasmaGlucose, 1541, 1563, "fasting glucose levels", "", "<http://ctro/data#Endpoint_24290> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose>."
92950, SymptomaticHypoglycemia, 1581, 1605, "symptomatic hypoglycemia", "", "<http://ctro/data#Endpoint_24295> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SymptomaticHypoglycemia>."
92962, InsulinGlargine, 1621, 1637, "insulin glargine", "", 
92911, PercentageAffected, 1649, 1655, "61 . 4", "", "<http://ctro/data#Outcome_24438> <http://ctro/data#hasPercentageAffected> \"61 . 4\"."
35, IsophaneInsulin_NPH, 1664, 1675, "NPH insulin", "", 
92972, PercentageAffected, 1687, 1689, "66", "", "<http://ctro/data#Outcome_24465> <http://ctro/data#hasPercentageAffected> \"66\"."
44, NocturnalHypoglycemia, 1706, 1728, "nocturnal hypoglycemia", "", "<http://ctro/data#Endpoint_24300> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#NocturnalHypoglycemia>."
92958, InsulinGlargine, 1736, 1752, "insulin glargine", "", 
55, RelativeReduction, 1774, 1776, "25", "", "<http://ctro/data#Outcome_24492> <http://ctro/data#hasRelativeChangeValue> \"25\"."
133, PercentageAffected, 1842, 1848, "26 . 5", "", "<http://ctro/data#Outcome_24492> <http://ctro/data#hasPercentageAffected> \"26 . 5\"."
134, PercentageAffected, 1854, 1860, "35 . 5", "", "<http://ctro/data#Outcome_24519> <http://ctro/data#hasPercentageAffected> \"35 . 5\"."
135, PvalueDiff, 1865, 1877, "P = 0 . 0136", "", "<http://ctro/data#DiffBetweenGroups_24546> <http://ctro/data#hasPvalueDiff> \"P = 0 . 0136\"."
28, InsulinGlargine, 1898, 1914, "insulin glargine", "", 
136, WeightGain, 1938, 1949, "weight gain", "", "<http://ctro/data#Endpoint_24305> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#WeightGain>."
92951, IsophaneInsulin_NPH, 1968, 1971, "NPH", "", 
56, Increment, 1980, 1985, "0 . 4", "", "<http://ctro/data#Outcome_24555> <http://ctro/data#hasChangeValue> \"HbA1c\". <http://ctro/data#Outcome_24555> <http://ctro/data#hasChangeValue> \"0 . 4\"."
57, Increment, 1991, 1996, "1 . 4", "", "<http://ctro/data#Outcome_24582> <http://ctro/data#hasChangeValue> \"HbA1c\". <http://ctro/data#Outcome_24582> <http://ctro/data#hasChangeValue> \"1 . 4\"."
58, Kg, 1997, 1999, "kg", "", "<http://ctro/data#Endpoint_24305> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg>."
139, PvalueDiff, 2002, 2014, "P < 0 . 0007", "", "<http://ctro/data#DiffBetweenGroups_24609> <http://ctro/data#hasPvalueDiff> \"P < 0 . 0007\"."
108, ConclusionComment, 2033, 2200, "In patients with type 2 diabetes , once - daily bedtime insulin glargine is as effective as once - or twice - daily NPH in improving and maintaining glycemic control .", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasConclusionComment> \"In patients with type 2 diabetes , once - daily bedtime insulin glargine is as effective as once - or twice - daily NPH in improving and maintaining glycemic control .\"."
92956, Type2Diabetes, 2050, 2065, "type 2 diabetes", "", 
65, Frequency, 2068, 2080, "once - daily", "", 
92961, Bedtime, 2081, 2088, "bedtime", "", 
29, InsulinGlargine, 2089, 2105, "insulin glargine", "", 
68, Frequency, 2125, 2148, "once - or twice - daily", "", 
36, IsophaneInsulin_NPH, 2149, 2152, "NPH", "", 
314, ConclusionComment, 2201, 2331, "In addition , insulin glargine deonstrates a lower risk of nocturnal hypoglycemia and less weight gain compared with NPH insulin .", "", "<http://ctro/data#ClinicalTrial_24258> <http://ctro/data#hasConclusionComment> \"In addition , insulin glargine deonstrates a lower risk of nocturnal hypoglycemia and less weight gain compared with NPH insulin .\"."
30, InsulinGlargine, 2215, 2231, "insulin glargine", "", 
66, NocturnalHypoglycemia, 2260, 2282, "nocturnal hypoglycemia", "", 
143, WeightGain, 2292, 2303, "weight gain", "", 
92971, IsophaneInsulin_NPH, 2318, 2329, "NPH insulin", "", 
92917, PMID, 2380, 2388, "11315821", "", "<http://ctro/data#Publication_24249> <http://ctro/data#hasPMID> \"11315821\"."
